Beckenham, United Kingdom

Jonathan Michael Davies


Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 79(Granted Patents)


Location History:

  • Fort Talbot, GB (1996)
  • Kent, GB (1998)
  • Beckenham, GB (1996 - 1999)

Company Filing History:


Years Active: 1996-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan Michael Davies

Introduction

Jonathan Michael Davies is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor ligands. With a total of five patents to his name, Davies has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Davies has developed compounds related to gastrin and CCK receptor ligands. These compounds are characterized by specific formulas, wherein A represents a group having two fused rings or a group of formula (Id). The compounds include various substituents and functional groups, such as K, which can be --O--, --S--, --CH.sub.2 --, --N(R.sup.2)--, or --N(COR.sup.2)--. The ligands he has developed are designed to interact with CCK and/or gastrin receptors, along with their pharmaceutically acceptable salts.

Career Highlights

Davies is currently associated with the James Black Foundation Limited, where he continues to innovate and contribute to the field of pharmaceutical research. His work has been instrumental in advancing the understanding of receptor interactions and their implications in drug development.

Collaborations

Some of his notable coworkers include Sarkis Barret Kalindjian and Caroline M Low. Their collaborative efforts have further enhanced the research and development initiatives at the James Black Foundation Limited.

Conclusion

Jonathan Michael Davies is a distinguished inventor whose work in receptor ligands has made a significant impact in the pharmaceutical industry. His innovative contributions continue to pave the way for advancements in drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…